Germline testing for predisposition to ovarian/breast cancer should be routinely recommended in all patients with invasive epithelial ovarian cancer

被引：0

作者：

Wheeler L.J. ^{[1
]}

Guntupalli S. ^{[1
]}

机构：

[1] Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado Denver, School of Medicine, Anschutz Medical Campus, 12631 East 17th Avenue B198-6, Aurora, 80045, CO

来源：

Indian Journal of Gynecologic Oncology | 2017年 / 15卷 / Suppl 1期

关键词：

Genetic testing; Ovarian cancer; Universal screening;

D O I：

10.1007/s40944-017-0164-7

中图分类号：

学科分类号：

摘要：

Given the marked prevalence of germline mutations among women with ovarian cancer, we recommend universal BRCA genetic screening, regardless of patient age or family history. © Association of Gynecologic Oncologists of India 2017.

引用

页码：S27 / S30

页数：3

共 50 条

[21] GENETIC PREDISPOSITION TO BREAST-CANCER AND OVARIAN-CANCER
LALLE, P
STOPPALYONNET, D
MAZOYER, S
RIO, P
GIRODET, C
HARDOUIN, A
NAROD, SA
SOBOL, H
BIGNON, YJ
LARRA, F
LORTHOLARY, A
PIET, L
LAITHIER, V
VUILLIER, J
DILHUYDY, MH
LONGY, M
TOULOUSE, C
COUETTE, JE
HARDOUIN, A
SWITSUS, O
CHAMOUTON, C
BIGNON, YJ
PLAGNE, R
PETIT, MF
CURE, H
CUISENIER, J
LIZARD, S
NIVELON
TEYSSIER, JY
MOUSSEAU
LEROUX, D
VROUSOS
SCHAERER
VENNIN, P
DEMAILLE, MC
DECIGNY, N
GRANIER, AM
DEYRAT, JP
SOBOL, H
DESSEIGNE, F
FRAPPAZ, D
FERVERS, B
EISINGER, F
FABBRO
LUPORSI, E
LEHEUP, B
SOMMELET, D
MAUGAUDLOUBOUTIN, C
FRENAY, M
GESTA, P
BULLETIN DU CANCER, 1993, 80 (10) : 857 - 865
[22] Imaging should be used for monitoring patients with epithelial ovarian cancer
Meier, W.
13TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI) HELD JOINTLY WITH THE GERMAN SOCIETY OF OBSTETRICS & GYNECOLOGY, 2010, : 71 - 72
[23] Predictive genetic testing for breast/ovarian cancer predisposition: Responsibility & communication with relatives
Foster, C
Watson, M
Moynihan, C
Ardern-Jones, A
Eeles, R
PSYCHO-ONCOLOGY, 2002, 11 (06) : 550 - 550
[24] Genetic testing for epithelial ovarian cancer
Amin, Noa
Chaabouni, Narda
George, Angela
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2020, 65 : 125 - 138
[25] Germline mutational spectrum in Armenian breast cancer patients suspected of hereditary breast and ovarian cancer
Mike M. Moradian
Davit T. Babikyan
Sione Markarian
Jonny G. Petrosyan
Nare Avanesian
Tereza Arutunyan
Tamara F. Sarkisian
Human Genome Variation, 8
[26] Germline mutational spectrum in Armenian breast cancer patients suspected of hereditary breast and ovarian cancer
Moradian, Mike M.
Babikyan, Davit T.
Markarian, Sione
Petrosyan, Jonny G.
Avanesian, Nare
Arutunyan, Tereza
Sarkisian, Tamara F.
HUMAN GENOME VARIATION, 2021, 8 (01)
[27] Real-world evidence on clinical value of germline alterations of cancer predisposition genes in Chinese epithelial ovarian cancer
Li, L.
Zhu, C.
Shao, D.
Wu, M.
GYNECOLOGIC ONCOLOGY, 2020, 159 : 145 - 145
[28] Germline mutations in Chinese ovarian cancer with or without breast cancer
Kwong, Ava
Ho, Cecilia Yuen Sze
Shin, Vivian Yvonne
Au, Chun Hang
Luk, Wing Pan
Fung, Ling Hiu
Chan, Tsun-Leung
Chan, Karen Kar Loen
Ngan, Hextan Yuen Sheung
Ma, Edmond Shiu Kwan
MOLECULAR GENETICS & GENOMIC MEDICINE, 2022, 10 (07):
[29] Multi-gene panel testing for hereditary cancer predisposition in unsolved high risk breast and ovarian cancer patients
Crawford, B. B.
Adams, S. B.
Sittler, T.
Van den Akker, J.
Chan, S. B.
Leitner, O.
Ryan, L. N.
Gil, E.
Van't Veer, L. J.
CANCER RESEARCH, 2017, 77
[30] Rates and results of germline genetic testing in patients with epithelial ovarian cancer at a tertiary care center.
Samborski, Alexandra
Wilbur, MaryAnn
Marshall, Lila
Mahon, Lauren
Anderson, Elizabeth
Thevenet-Morrison, Kelly
Underhill-Blazey, Meghan
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17607 - E17607

← 1 2 3 4 5 →